ATE197127T1 - Verwendung von gallsäure-aktiviertem lipase als diätsupplement - Google Patents

Verwendung von gallsäure-aktiviertem lipase als diätsupplement

Info

Publication number
ATE197127T1
ATE197127T1 AT93203480T AT93203480T ATE197127T1 AT E197127 T1 ATE197127 T1 AT E197127T1 AT 93203480 T AT93203480 T AT 93203480T AT 93203480 T AT93203480 T AT 93203480T AT E197127 T1 ATE197127 T1 AT E197127T1
Authority
AT
Austria
Prior art keywords
gallic acid
activated lipase
lipase
diet supplement
activated
Prior art date
Application number
AT93203480T
Other languages
English (en)
Inventor
Jordan J N Tang
Chi-Sun Wang
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE197127T1 publication Critical patent/ATE197127T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1216—Other enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
AT93203480T 1987-11-19 1988-11-18 Verwendung von gallsäure-aktiviertem lipase als diätsupplement ATE197127T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/122,410 US4944944A (en) 1987-11-19 1987-11-19 Dietary compositions and methods using bile salt-activated lipase

Publications (1)

Publication Number Publication Date
ATE197127T1 true ATE197127T1 (de) 2000-11-15

Family

ID=22402581

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88310942T ATE167982T1 (de) 1987-11-19 1988-11-18 Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase
AT93203480T ATE197127T1 (de) 1987-11-19 1988-11-18 Verwendung von gallsäure-aktiviertem lipase als diätsupplement

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT88310942T ATE167982T1 (de) 1987-11-19 1988-11-18 Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase

Country Status (7)

Country Link
US (1) US4944944A (de)
EP (2) EP0317355B1 (de)
JP (2) JP2592939B2 (de)
AT (2) ATE167982T1 (de)
DE (2) DE3856214T2 (de)
ES (2) ES2152941T3 (de)
GR (1) GR3035093T3 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5000975A (en) * 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
US5008120A (en) * 1989-07-21 1991-04-16 Snow Brand Milk Products Co., Ltd. Method of preparing iron-fortified beverage
US5173408A (en) * 1989-11-13 1992-12-22 Lange Louis George Iii Mammalian pancreatic cholesterol esterase
JP2808166B2 (ja) * 1990-04-26 1998-10-08 雪印乳業株式会社 鉄強化飲料の製造方法
US5186961A (en) * 1991-03-15 1993-02-16 North Carolina State University Method and composition for maintaining animals on a keratin-containing diet
US5169666A (en) * 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
US5902617A (en) * 1992-05-19 1999-05-11 Pabst; Patrea L. Enzyme supplemented baby formula
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5460812A (en) * 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
AU750891B2 (en) 1996-12-06 2002-08-01 Aventis Pharmaceuticals Inc. Polypeptides encoded by a human lipase-like gene, compositions and methods
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products
US6399090B1 (en) * 1998-06-05 2002-06-04 Insotech Ltd. Insulin supplemented infant formula
DE69939900D1 (de) * 1998-06-05 2008-12-24 Nutrinia Ltd Insulin angereichertes säuglingsnährpräparat
AU5032600A (en) * 1999-05-19 2001-12-03 Barnes-Jewish Hospital Enhanced triglyceride digestion in a deficiency of bile salts
EP1059041A1 (de) * 1999-06-07 2000-12-13 Universiteit Gent Kombinierte Verwendung von Triglyceriden mit mittelkettigen Fettsäuren und exogenen lipolytischen Enzymen als Futterzusätze
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
EP1539222A1 (de) * 2002-07-02 2005-06-15 The Regents Of The University Of California Behandlung von augenerkrankungen
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
CA2515583C (en) 2003-03-07 2015-07-14 Diversa Corporation Hydrolases, nucleic acids encoding them and methods for making and using them
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
EP1987142A4 (de) 2006-02-02 2009-07-15 Verenium Corp Esterasen und damit zusammenhängende nukleinsäuren und verfahren
AR059692A1 (es) * 2007-03-01 2008-04-23 Adriana Fernandez Alimento de alto contenido calorico y de facil digestion
US8153391B2 (en) 2008-08-29 2012-04-10 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8198062B2 (en) 2008-08-29 2012-06-12 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
US8357503B2 (en) 2008-08-29 2013-01-22 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
AU2010362575A1 (en) 2010-10-21 2013-04-11 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
JP5850940B2 (ja) 2010-10-21 2016-02-03 スウェディッシュ オーファン バイオビトラム パブリーク アクチエボラグ ヒト乳児の発育速度を増大させる方法
IL313986B1 (en) 2012-02-17 2026-05-01 Alcresta Inc Methods, compositions and devices for supplying dietary fatty acid needs
GB201501081D0 (en) * 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
AU2017237164A1 (en) 2016-03-24 2018-10-11 Nutrinia Ltd. Use of insulin for promoting gastric emptying
US11045396B2 (en) 2017-08-17 2021-06-29 Alcresta Therapeutics, Inc. Devices and methods for the supplementation of a nutritional formula

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA662815A (en) * 1963-05-07 G. Farnham Merle Treatment for "scours" in mammals
US3256150A (en) * 1964-04-20 1966-06-14 Dairyland Food Lab Method for treating malabsorption syndrome
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
JPS5017559B2 (de) * 1972-09-20 1975-06-21
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
DE2638089C2 (de) * 1976-08-24 1985-04-25 Degussa Ag, 6000 Frankfurt Lipase-Präparate mit verbesserter Wirkung
GB1571877A (en) * 1978-04-24 1980-07-23 Meito Sangyo Kk Microbial lipase and its preparation
JPS6047858B2 (ja) * 1978-09-20 1985-10-24 田村 輝 温浴用水製造装置
DE2923279C2 (de) * 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
DE3586122D1 (de) * 1985-01-09 1992-07-02 Genencor Inc Ueberfuehrung von exogenen stoffen in kaesebruch.
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase

Also Published As

Publication number Publication date
EP0605913A1 (de) 1994-07-13
EP0605913B1 (de) 2000-10-25
DE3856214D1 (de) 1998-08-13
EP0317355A3 (de) 1991-07-17
JPH06315347A (ja) 1994-11-15
DE3856435T2 (de) 2001-03-29
JPH01231848A (ja) 1989-09-18
ES2120402T3 (es) 1998-11-01
ES2152941T3 (es) 2001-02-16
JP2592939B2 (ja) 1997-03-19
HK1023031A1 (en) 2000-08-25
EP0317355B1 (de) 1998-07-08
ATE167982T1 (de) 1998-07-15
GR3035093T3 (en) 2001-03-30
EP0317355A2 (de) 1989-05-24
DE3856435D1 (de) 2000-11-30
HK1012213A1 (en) 1999-07-30
DE3856214T2 (de) 1998-12-17
US4944944A (en) 1990-07-31

Similar Documents

Publication Publication Date Title
DE3856435D1 (de) Verwendung von Gallsäure-aktiviertem Lipase als Diätsupplement
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
Lien et al. The effect of triglyceride positional distribution on fatty acid absorption in rats
JPS6466118A (en) Free fatty acid for treating or preventing chronic articular rheumatism
US6699496B1 (en) Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form
Kinsell et al. Essential fatty acids, lipid metabolism, and atherosclerosis
DK0515460T4 (da) Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme
NL990032I2 (nl) Vetemulsie, werkwijze voor de bereiding daarvan ende toepassing daarvan.
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
PT754001E (pt) Produto nutricional para tratamento da colite ulcerosa e sua utilizacao
IE791001L (en) Acyl-carnitines with triglycerides
EP0315113A3 (de) Innere Ester von Gangliosiden mit analgetisch-entzündungshemmender Aktivität
KR20050111611A (ko) 아라키돈산의 하주일(下週日) 리듬 정상화용 용도
ZA971134B (en) Multifunctional fat absorption and blood cholesterol reducing formulation.
JPS6466119A (en) Free fatty acid for treating diabetes
US20110218151A1 (en) Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
DE3877723D1 (de) Diaetoel.
ZA905437B (en) Pharmaceutical and dietary uses of fatty acids
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
McPherson et al. Specificity of an Intestinal Lipase for Monoglycerides.
Suttie et al. Fat utilization in the fluoride-fed rat
EP0198804A3 (de) Diätetische Zusammensetzung und Verfahren zu ihrer Herstellung
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)
Blaton et al. The human plasma lipids and lipoproteins under influence of EPL-therapy
FR2438481A1 (fr) Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time